Q57782528 | A Single-Center Surgical Experience of 122 Patients With Single and Multiple Hepatocellular Adenomas |
Q57782562 | A bulky single mass of the liver that revealed a primary hepatic leiomyosarcoma |
Q91737631 | A giant bleeding liver mucinous cystic neoplasm |
Q45360205 | A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis |
Q28179840 | A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia |
Q96111245 | ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice |
Q39574511 | Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis |
Q57782605 | Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer |
Q56925249 | Abnormal Plasma Microparticles Impair Vasoconstrictor Responses in Patients With Cirrhosis |
Q53196323 | Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. |
Q57782582 | Acute pulmonary embolism |
Q38318297 | Alcohol increases tumor necrosis factor alpha and decreases nuclear factor-kappab to activate hepatic apoptosis in genetically obese mice |
Q51892502 | Algorithm for immediate cytologic diagnosis of hepatic tumors. |
Q34001610 | Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation |
Q43037388 | An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection |
Q43467387 | Analysis of incidence and pattern of acute rejection episodes after simultaneous pancreas and kidney transplantation |
Q53217212 | Anti-angiogenic effect of metformin in human liver carcinogenesis related to metabolic syndrome. |
Q57782614 | Antioxidant enzymatic activities and renal warm ischemia: correlation with the duration of ischemia |
Q35105721 | Approaches for treatment of liver fibrosis in chronic hepatitis C |
Q42199539 | Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation. |
Q42277660 | Assessment of chronic rejection in liver graft recipients receiving immunosuppression with low-dose calcineurin inhibitors. |
Q44661944 | Assessment of hepatic steatosis by expert pathologists: the end of a gold standard |
Q53521945 | Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour. |
Q53567989 | Aurora-A/STK-15 is a predictive factor for recurrent behaviour in non-invasive bladder carcinoma: a study of 128 cases of non-invasive neoplasms. |
Q57782632 | Bcl-2 and Bax expression on rat ischemic kidney |
Q45958504 | Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. |
Q37807575 | Benign Liver Tumors: An update |
Q57782445 | Benign and malignant hepatocellular lesions in patients with vascular liver disease |
Q57782490 | Benign liver lesions |
Q37969722 | Beyond "cirrhosis": a proposal from the International Liver Pathology Study Group |
Q37554449 | Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma |
Q55054786 | Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases. |
Q57782620 | CD44 IS AN INDEPENDENT PROGNOSTIC FACTOR IN CONVENTIONAL RENAL CELL CARCINOMAS |
Q43644252 | CD44 is an independent prognostic factor in conventional renal cell carcinomas |
Q57782622 | Caverno-pudendal nervous communicating branches in the penile hilum |
Q73150709 | Caverno-pudendal nervous communicating branches in the penile hilum |
Q57782494 | Cellular and molecular techniques |
Q35071429 | Changes in autophagic response in patients with chronic hepatitis C virus infection |
Q57782508 | Changing trends in malignant transformation of hepatocellular adenoma |
Q57782625 | Chester-Erdheim disease: A neoplastic disorder |
Q46755865 | Cholangiocarcinoma: epidemiology and global management |
Q57782523 | Cholangiocarcinome périphérique : corrélations radiopathologiques |
Q50864501 | Clonal analysis of macronodules in cirrhosis. |
Q38470673 | Clonal analysis of renal sporadic angiomyolipomas |
Q57782496 | Colon Tumor Growth and Antivascular Treatment in Mice: Complementary Assessment with MR Elastography and Diffusion-weighted MR Imaging |
Q90208486 | Combining imaging and tumour biopsy improves the diagnosis of combined hepatocellular-cholangiocarcinoma |
Q57782544 | Comment classer une tumeur hépatocytaire bénigne en 2008 ? |
Q44911533 | Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas |
Q46157058 | Comparison of four embolic materials for portal vein embolization: experimental study in pigs |
Q51927013 | Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. |
Q42272013 | Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration |
Q57782449 | Complete spontaneous liver graft disappearance after auxiliary liver transplantation |
Q57782452 | Congenital hepatic fibrosis with multiple HNF1α hepatocellular adenomas |
Q46317294 | Congenital portosystemic shunts associated with liver tumours. |
Q57782399 | Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan®: A Comparative Study with the M Probe and Liver Biopsy |
Q57782407 | Correlation of tumor response on computed tomography with pathological necrosis in hepatocellular carcinoma treated by chemoembolization before liver transplantation |
Q46360745 | Cullin7: a new gene involved in liver carcinogenesis related to metabolic syndrome |
Q57782499 | Cystic hepatobiliary neoplasia |
Q34015966 | Definition and natural history of metabolic steatosis: histology and cellular aspects |
Q38985806 | Detection of liver micrometastases from colorectal origin by perfusion CT in a rat model |
Q54441244 | Development of Collateral Pathways in Tumor Obstruction of Confluence of the Hepatic Veins: Neither Fortuitous nor Innocuous. |
Q38773241 | Diabetes mellitus in patients with cirrhosis: clinical implications and management |
Q38245338 | Diagnosis and management of solid benign liver lesions. |
Q38018227 | Diffusion-weighted MR imaging for the regional characterization of liver tumors. |
Q39186073 | Diffusion-weighted and T2-weighted MR imaging for colorectal liver metastases detection in a rat model at 7 T: a comparative study using histological examination as reference. |
Q39995898 | Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy |
Q28581948 | Dystroglycan expression in hepatic stellate cells: role in liver fibrosis |
Q39007454 | EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition. |
Q45125034 | Effect of isoproterenol on the cardiac troponin I degradation and release during early TNFalpha-induced ventricular dysfunction in isolated rabbit heart |
Q50588057 | Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients. |
Q57184374 | Endothelial cell-derived microparticles loaded with iron oxide nanoparticles: feasibility of MR imaging monitoring in mice |
Q38968181 | Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks. |
Q43868971 | Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma |
Q43039600 | Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study |
Q57782565 | Expression of Epidermal Growth Factor Receptor and Proliferative Activity of Cyst Epithelium in Human Renal Cystic Diseases |
Q57782638 | Expression of aldehydic lipid peroxidation products in rat kidneys during warm ischemia |
Q40926848 | Expression of connective tissue growth factor in experimental rat and human liver fibrosis |
Q57782599 | Expression of cyclooxygenase 2 and prostaglandin E synthase after renal ischemia-reperfusion |
Q39277652 | Extended liver resection for polycystic liver disease can challenge liver transplantation. |
Q44688577 | Fat deposition decreases diffusion parameters at MRI: a study in phantoms and patients with liver steatosis |
Q37523542 | Fibrosis in Chronic Hepatitis C: Correlation between Immunohistochemically-Assessed Virus Load with Steatosis and Cellular Iron Content |
Q57782423 | Follow-up Imaging After Liver Transplantation Should Take Into Consideration Primary Hepatocellular Carcinoma Characteristics |
Q53321179 | Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer. |
Q36733943 | Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C. |
Q39003817 | Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation |
Q57782566 | Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC |
Q33250475 | Global proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansion. |
Q40578851 | Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors |
Q57782572 | Glycomics: A new taste of cirrhosis marker |
Q53342426 | Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. |
Q38992720 | Hepatic Fibrosis, Inflammation, and Steatosis: Influence on the MR Viscoelastic and Diffusion Parameters in Patients with Chronic Liver Disease. |
Q30488507 | Hepatic fat fraction and visceral adipose tissue fatty acid composition in mice: Quantification with 7.0T MRI. |
Q35645088 | Hepatic proliferation and angiogenesis markers are increased after portal deprivation in rats: a study of molecular, histological and radiological changes. |
Q38720943 | Hepatocellular Adenomas: WHO Classification and Immunohistochemical Workup |
Q45269686 | Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification |
Q36716630 | Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor. |
Q36758898 | Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison |
Q37769343 | Hepatocellular carcinoma--what's new? |
Q51665999 | Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. |
Q53217245 | Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders. |
Q57779831 | Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors |
Q43521896 | High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis. |
Q43755024 | High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis |
Q38093561 | High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging |
Q57782512 | High serum level of alpha-fetoprotein in focal nodular hyperplasia of the liver |
Q57782429 | Histology/pathology |
Q51353878 | Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. |
Q57782474 | Histopathology of Hepatocellular Carcinoma |
Q35010290 | Hypoxia pathways and cellular stress activate pancreatic stellate cells: development of an organotypic culture model of thick slices of normal human pancreas |
Q57782627 | IN SITU DETECTION OF LIPID PEROXIDATION BY-PRODUCTS AS MARKERS OF RENAL ISCHEMIA INJURIES IN RAT KIDNEYS |
Q33211462 | Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases |
Q57782574 | Image of the Month |
Q33933462 | Imaging mass spectrometry provides fingerprints for distinguishing hepatocellular carcinoma from cirrhosis |
Q34647317 | Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas |
Q44042540 | Impact of different combined preservation modalities on warm ischemic kidneys: effect on oxidative stress, hydrostatic perfusion characteristics and tissue damage |
Q47851362 | In situ detection of lipid peroxidation by-products as markers of renal ischemia injuries in rat kidneys |
Q35126024 | In situ proteomic analysis by MALDI imaging identifies ubiquitin and thymosin-β4 as markers of malignant intraductal pancreatic mucinous neoplasms |
Q57782557 | In the new area of noninvasive markers of hepatocellular carcinoma |
Q42510427 | In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats |
Q53478097 | In vivo anisotropic mechanical properties of dystrophic skeletal muscles measured by anisotropic MR elastographic imaging: the mdx mouse model of muscular dystrophy. |
Q44332232 | In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C. |
Q46702703 | Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease |
Q56925226 | Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis |
Q43039572 | Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation |
Q43047910 | Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis |
Q42989933 | Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C. |
Q41722162 | Interactions between virus-related factors and post-transplant ascites in patients with hepatitis C and no cirrhosis: role of cryoglobulinemia |
Q57153664 | Intracystic concentrations of tumour markers for the diagnosis of cystic liver lesions |
Q57782559 | Intraductal papillary mucinous tumors of both biliary and pancreatic ducts |
Q57782617 | Is renal preservation with pulsatile perfusion a model for reperfusion? |
Q57782576 | Liver Gene Expression Signature of Mild Fibrosis in Patients With Chronic Hepatitis C |
Q99707843 | Liver adenomatosis and NAFLD developed in the context of hereditary fructose intolerance |
Q36591012 | Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings |
Q35170449 | Liver extracellular matrix in health and disease |
Q37767323 | Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT. |
Q37398932 | Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression |
Q51808978 | Liver repopulation trial using bone marrow cells in a retrorsine-induced chronic hepatocellular injury model. |
Q38161773 | Liver resection in patients with hepatic hereditary hemorrhagic telangiectasia |
Q57137596 | Liver steatosis assessed by preoperative MRI: An independent risk factor for severe complications after major hepatic resection |
Q34584336 | Liver transplantation for hepatocellular carcinoma: role of biopsy. |
Q53394857 | Liver tumours in patients with Fanconi anaemia: a report of three cases. |
Q39493807 | Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells. |
Q53201713 | Loss of ezrin in human intrahepatic cholangiocarcinoma is associated with ectopic expression of E-cadherin. |
Q57782416 | MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors |
Q57782481 | MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours |
Q57145707 | Massive biliary necrosis as a complication of a hereditary hemorrhagic telangiectasia |
Q57782593 | Measurement of telomere length on tissue sections using quantitative fluorescencein situ hybridization (Q-FISH) |
Q36212867 | Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features |
Q39113102 | Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation |
Q39451319 | Molecular classification of hepatocellular adenoma in clinical practice |
Q42990096 | Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. |
Q57782568 | Multiple mixed adenoma-focal nodular hyperplasia of the liver associated with spontaneous intrahepatic porto-systemic shunt: a new type of vascular malformation associated with the multiple focal nodular hyperplasia syndrome? |
Q53208279 | Neither preoperative computed tomography nor intra-operative examination can predict metastatic lymph node in the hepatic pedicle in patients with colorectal liver metastasis. |
Q51287154 | Neurotensin regulation induces overexpression and activation of EGFR in HCC and restores response to erlotinib and sorafenib. |
Q57782435 | Obesity and Fatty Pancreatic Infiltration Are Risk Factors for Pancreatic Precancerous Lesions (PanIN) |
Q53076833 | Obliterative portal venopathy: portal hypertension is not always present at diagnosis. |
Q35183888 | Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease |
Q36713620 | Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update |
Q57782479 | Pathologie hépatique Cirrhose et carcinome hépatocellulaire : indications et rôles de la biopsie hépatique |
Q44570406 | Pathology of cholangiocarcinoma |
Q57782515 | Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet |
Q57782569 | Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma Before Liver Transplantation: A Prospective Study with Histopathologic Comparison |
Q57782438 | Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion |
Q33539003 | Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary study |
Q57782600 | Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis |
Q42339215 | Pre-therapy liver transcriptome landscape in Indian and French patients with severe alcoholic hepatitis and steroid responsiveness. |
Q39987989 | Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab |
Q57782463 | Preoperative tumour biopsy does not affect the oncologic course of patients with transplantable HCC |
Q53191508 | Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study. |
Q57782578 | Primary Hepatic Malignant Neoplasms: Radiologic-Pathologic Correlations |
Q35198372 | Progression from cirrhosis to cancer is associated with early ubiquitin post-translational modifications: identification of new biomarkers of cirrhosis at risk of malignancy |
Q54135674 | Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. |
Q57782608 | Prospective Evaluation of Ki–67 Labeling in Predicting the Recurrence and Progression of Superficial Bladder Transitional Cell Carcinoma |
Q34072811 | Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreas |
Q37993500 | Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection |
Q48068063 | Quantification of apolipoprotein A-I and B messenger RNA in heavy drinkers according to liver disease |
Q53375430 | Quantitative RT-PCR in cirrhotic nodules reveals gene expression changes associated with liver carcinogenesis. |
Q35597990 | Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease. |
Q57782526 | Quoi de neuf dans la prise en charge du carcinome hépatocellulaire sur cirrhose ? |
Q40998790 | Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients |
Q57782611 | Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas |
Q113871113 | Reply to: Correspondence regarding “Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies” |
Q38751392 | Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation. |
Q42985747 | Role of replicative senescence in the progression of fibrosis in hepatitis C virus (HCV) recurrence after liver transplantation. |
Q42045352 | SCG10 expression on activation of hepatic stellate cells promotes cell motility through interference with microtubules |
Q36773151 | SSAT/AHPBA joint symposium on evaluation and treatment of benign liver lesions |
Q57782629 | SUCCESSFUL TREATMENT OF ENCRUSTED PYELITIS IN A RENAL TRANSPLANT WITH LOCAL ACIDIFICATION AND SURGICAL ILEOCALICEAL ANASTOMOSIS |
Q39618705 | Selective portal vein ligation and embolization induce different tumoral responses in the rat liver |
Q42148070 | Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden |
Q33246213 | Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirin |
Q57782538 | Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery |
Q40238516 | Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH). |
Q33629823 | Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue |
Q35102345 | Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas |
Q35597379 | Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation |
Q38734213 | Strong antineoplastic effects of metformin in preclinical models of liver carcinogenesis |
Q73007062 | Successful treatment of encrusted pyelitis in a renal transplant with local acidification and surgical ileocaliceal anastomosis |
Q57782602 | Surgical injuries occurring during kidney procurement performed by a renal transplantation team |
Q44501598 | Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome. |
Q53548617 | TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma. |
Q36863160 | Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. |
Q35159416 | Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases |
Q47635380 | Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. |
Q57782645 | The course of hepatitis C virus infection after liver transplantation |
Q43041384 | The course of hepatitis C virus infection after liver transplantation |
Q46713524 | The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response. |
Q92679884 | The histone acetyltransferase hMOF promotes vascular invasion in hepatocellular carcinoma |
Q44560747 | The long-term effect of switching from cyclosporin A to mycophenolate mofetil in chronic renal graft dysfunction compared with conventional management. |
Q47439670 | The role of replicative senescence in chronic allograft nephropathy. |
Q43205518 | The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study |
Q57782547 | Thrombose portale tumorale et métastase hépatique de cancer colorectal |
Q43124491 | Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib |
Q46688979 | Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature. |
Q35134122 | Tumoral heterogeneity of hepatic cholangiocarcinomas revealed by MALDI imaging mass spectrometry |
Q57782506 | Tumors of the liver |
Q46157319 | Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure |
Q30868571 | Use of laser capture microdissection for clonal analysis |
Q40460115 | Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study. |
Q57782604 | Value of lipid peroxidation by-products detected during the renal procurement on renal graft function |
Q36296298 | Variant differentiation patterns in primary liver carcinoma |
Q51308854 | Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats. |
Q30440141 | Viscoelastic parameters for quantifying liver fibrosis: three-dimensional multifrequency MR elastography study on thin liver rat slices. |
Q46122797 | Well-differentiated hepatocellular neoplasm of uncertain malignant potential |
Q57782618 | What is the value of procurement biopsy lipid peroxidation lesions in the assessment of kidney graft function? |
Q41114489 | When Should We Propose Liver Transplant After Resection of Hepatocellular Carcinoma? A Comparison of Salvage and De Principe Strategies |
Q53401358 | [Prognosis factors of cholangiocarcinoma: contribution of recent molecular biology tools]. |
Q57782612 | hTERT expression in sporadic renal cell carcinomas |
Q53328591 | p63 gene expression study and early bladder carcinogenesis. |